Related Experiment Videos
[Coronary angioplasty in elderly patients]
E Eeckhout1, J C Stauffer, P Vogt
1Division de cardiologie, CHUV, Lausanne.
Praxis
|February 6, 1996
Summary
Percutaneous transluminal coronary angioplasty (PTCA) effectively treats severe angina in elderly patients, even with drug-resistant symptoms. This procedure offers significant clinical improvement and prolonged relief for older individuals with coronary heart disease.
Area of Science:
- Cardiology
- Interventional Cardiology
Context:
- Symptomatic coronary heart disease is common in the elderly.
- Optimal pharmacotherapy may not be sufficient for refractory angina.
Purpose:
- To evaluate the efficacy and safety of percutaneous transluminal coronary angioplasty (PTCA) in elderly patients (≥80 years) with severe, drug-resistant angina.
- To assess clinical outcomes, including restenosis, survival, and freedom from myocardial events.
Summary:
- A study of 91 elderly patients (mean age 80 years) undergoing 133 PTCA procedures for refractory angina.
- High angiographic success rate (84%) with acceptable adverse event rates (14%).
- Kaplan-Meier analysis showed 89% survival and 60% freedom from myocardial events at follow-up, with 24% symptomatic restenosis.
Impact:
- PTCA is an efficient and acceptable treatment option for elderly patients with severe and drug-resistant angina.
- The majority of patients remained asymptomatic two years post-PTCA, demonstrating long-term benefits.